Determination of antifungal MICs by a rapid susceptibility assay

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 333-340

  Riesselman, Marcia H ^a   Hazen, Kevin C ^b   Cutler, Jim E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; GLUCOSE;

ACCURACY; ANALYTICAL EQUIPMENT; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COLORIMETRY; DILUTION; FUNGUS; GLUCOSE UTILIZATION; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; FLUCONAZOLE; GLUCOSE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; TIME FACTORS;

EID: 0033988871     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Amsterdam, D. 1996. Susceptibility testing of antimicrobials in liquid media, p. 52-111. In V. Lorian (ed.), Antimicrobics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
2. Anaissie, E., V. Paetznick, and G. P. Bodey. 1991. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob. Agents Chemother. 35:1641-1646.
3. Blake, D. A., and N. V. McLean. 1989. A colorimetric assay for the measurement of D-glucose consumption by cultured cells. Anal. Biochem. 177: 156-160.
4. Hazen, K. C., D. L. Brawner, M. H. Riesselman, M. A. Jutila, and J. E. Cutler. 1991. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect. Immun. 59:907-912.
5. Hazen, K. C., and G. Wu. 1999. Kill power of oral antifungals against dermatophytes. Pediatr. Infect. Dis. J. 18:200-204.
6. Kanbe, T., Y. Han, B. Redgrave, M. H. Riesselman, and J. E. Cutler. 1993. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect. Immun. 61:2578-2584.
7. LaRocco, M. 1997. Recent developments in antifungal susceptibility testing. Clin. Microbiol. Newl. 13:81-85.
8. McGinnis, M. R., and M. G. Rinaldi. 1996. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids, p. 176-211. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
9. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Okajima, T., K. Nakamura, H. Zhang, N. Ling, T. Tanabe, T. Yasuda, and R. G. Rosenfeld. 1992. Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology 130:2201-2212.
11. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards-recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytasine. J. Clin. Microbiol. 33:1104-1107.
12. Pfaller, M. A., and M. G. Rinaldi. 1993. Antifungal susceptibility testing: current state of technology, limitations, and standardization. Infect. Dis. Clin. N. Am. 7:435-444.
13. Warnock, D. W. 1989. Antifungal drug susceptibility testing. Curr. Top. Med. Mycol. 3:403-416.